8-KMaterial AgreementsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Material Agreement (Mar 2, 2005)

Filed March 2, 2005For Securities:TMO

Summary

This 8-K filing from Thermo Fisher Scientific Inc. (formerly Thermo Electron Corporation) details significant decisions made by its Board of Directors and Compensation Committee regarding executive and director compensation, effective February 2005. Key actions include the approval of 2004 cash bonuses for executive officers, with payouts adjusted based on performance metrics. For 2005, the company established performance criteria for annual cash incentives, focusing on Adjusted EBITA and a balanced approach of financial (revenue and earnings growth) and qualitative measures. Additionally, the filing outlines base salary increases for most executive officers (excluding the CEO and General Counsel), and grants of stock options and restricted stock to key executives, including the CEO, Marijn E. Dekkers, and restricted stock to the Chairman of the Board, Jim P. Manzi. These compensation adjustments and incentive structures are designed to align executive pay with company performance and shareholder value.

Key Highlights

  • 1Thermo Fisher Scientific (TMO) approved cash bonuses for 2004 executive compensation, with the Compensation Committee exercising discretion to adjust payout amounts based on performance metrics.
  • 2Performance criteria for 2005 annual cash incentives were established, with Adjusted EBITA as a key metric under the 162(m) Plan.
  • 3The 2005 annual incentive program incorporates a blend of financial measures (revenue growth and earnings as a percentage of revenue) and qualitative measures for executive officers.
  • 4Effective April 1, 2005, most executive officers (excluding CEO and General Counsel) will receive base salary increases for 2005.
  • 5Stock options were granted to executive officers, with vesting over three years and an exercise price based on the average of opening and closing stock prices on the grant date.
  • 6CEO Marijn E. Dekkers received a significant stock option grant and an award of 100,000 restricted shares, also vesting over three years.
  • 7Director compensation was adjusted, with an increased annual retainer for the Audit Committee Chairman and restricted stock awards for the Chairman of the Board.

Frequently Asked Questions

For 2005, Thermo Fisher Scientific established performance criteria for annual cash incentives tied to Adjusted EBITA and a mix of financial (revenue and earnings growth) and qualitative performance measures. Most executive officers also saw base salary increases effective April 1, 2005, alongside stock option and restricted stock grants designed to align executive interests with company performance.

The 2004 cash bonuses for executive officers were approved under the 162(m) Plan. The Compensation Committee used its discretion to lower bonus payouts based on its assessment of supplemental performance metrics achieved under the company's annual cash incentive program.

Stock options granted to executive officers vest in equal annual installments over three years, have an exercise price equal to the average of the opening and closing stock prices on the grant date, and a 7-year term. CEO Marijn E. Dekkers also received 100,000 restricted shares that vest over three years, commencing November 21, 2005.

Yes, the annual cash retainer for the Chairman of the Audit Committee was increased to $20,000, effective February 25, 2005. Additionally, the Chairman of the Board, Jim P. Manzi, was awarded restricted stock vesting over three years.